Ability Pharma (private company)

See something wrong or missing? Let us know
Offices:
Barcelona
Business model:
B2B
Investors:
we tracked 3 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 2 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

AbilityPharma is a clinical-stage biopharmaceutical company focused on developing first-in-class causing autophagy molecules through binding to the nuclear receptors PPARα and PPARγ and inducing Reticular Stress (ER-Stress).  It represents a novel approach, offering an opportunity to create important new therapeutic options for cancer patients.

Companies with similar profile to Ability Pharma:

CompanyCriteria
Spain Amadix
66%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Oxolife SL
65%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • At least one other investor: Capital Cell
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Qrem
56%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain ViveBiotech
56%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain Dietox
56%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: Inveready
  • Minim one investor from outside Scandinavia: Yes
Spain Fesia Technology
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: Capital Cell
  • Minim one investor from outside Scandinavia: Yes
Spain MoWoot
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: Capital Cell
  • Minim one investor from outside Scandinavia: Yes
France Domalys
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Devicare
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: Capital Cell
  • Minim one investor from outside Scandinavia: Yes
United Kingdom TestCard
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Spain Oncomatryx
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
France Synapse Medicine
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Norlase
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Switzerland Neo Medical
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
France Lucine
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Spain eKuore
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: Capital Cell
  • Minim one investor from outside Scandinavia: Yes
Norway Prediktor
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Ireland Venari Medical
54%
  • Similar verticals: Health services, Manufacturing
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Germany Aignostics
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes
Germany Semalytix
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
  • Minim one investor from outside Scandinavia: Yes